Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-10 Zummo Jacqueline Chf Scientific Operations Off Shares withheld for taxes −5,225 $3.00 $16K 71,573
2023-01-10 Shefferman Jesse CEO and President Shares withheld for taxes −5,855 $3.00 $18K 866,982
2023-01-10 Bandari Jathin Chief Medical Officer Shares withheld for taxes −1,876 $3.00 $6K 18,442
2023-01-03 Zummo Jacqueline Chf Scientific Operations Off Shares withheld for taxes −2,159 $2.80 $6K 76,798
2023-01-03 Shefferman Jesse CEO and President Shares withheld for taxes −6,604 $2.80 $18K 872,837
2023-01-03 Fry Hannah VP, Controller Shares withheld for taxes −361 $2.80 $1K 27,239
2022-12-30 Opaleye Management Inc. 10% owner Sale +13,173 $2.71 $36K 2,562,594
2022-12-30 Opaleye Management Inc. 10% owner Sale +2,300 $2.71 $6K 130,000
2022-09-15 Opaleye Management Inc. 10% owner Purchase +5,000 $3.80 $19K 2,575,777
2022-09-15 Opaleye Management Inc. 10% owner Purchase +2,300 $3.80 $9K 132,300
2022-09-14 Opaleye Management Inc. 10% owner Purchase +14,100 $3.98 $56K 2,570,777
2022-09-14 Opaleye Management Inc. 10% owner Purchase +2,500 $3.98 $10K 130,000
2022-08-11 Shefferman Jesse CEO and President Purchase +9,065 $3.84 $35K 879,441
2022-07-16 Fry Hannah VP, Controller Grant or award +25,000 27,600
2022-07-15 Davis Blaine Chief Financial Officer Shares withheld for taxes −5,081 $3.13 $16K 20,662
2022-07-01 Bandari Jathin Chief Medical Officer Shares withheld for taxes −682 $3.22 $2K 20,318
2022-06-30 BESHAR LUKE M Director Purchase +10,000 $3.10 $31K 198,000
2022-06-08 Huang Jane Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 Flannelly Barry P Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2022-06-08 Levy Richard S Director Grant or award · Stock Option (Right to Buy) +10,000 10,000

Page 9 of 17 · 335 trades